Invivyd, Inc. - IVVD

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 6.0% 16,653,036 View
Feb 17, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 6.0% 16,653,036 View
Feb 17, 2026 SCHEDULE 13G/A Steven A. Cohen 6.0% 16,653,036 View
Feb 17, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND L P 4.9% 13,619,218 View
Feb 17, 2026 SCHEDULE 13G/A BVF I GP LLC 4.9% 13,619,218 View
Feb 17, 2026 SCHEDULE 13G/A BIOTECHNOLOGY VALUE FUND II LP 3.6% 9,954,397 View
Feb 17, 2026 SCHEDULE 13G/A BVF II GP LLC 3.6% 9,954,397 View
Feb 17, 2026 SCHEDULE 13G/A Biotechnology Value Trading Fund OS LP 0.6% 1,563,852 View
Feb 17, 2026 SCHEDULE 13G/A BVF Partners OS Ltd. 0.6% 1,563,852 View
Feb 17, 2026 SCHEDULE 13G/A BVF GP HOLDINGS LLC 8.3% 23,573,615 View
Feb 17, 2026 SCHEDULE 13G/A BVF PARTNERS L P/IL 9.0% 25,525,000 View
Feb 17, 2026 SCHEDULE 13G/A BVF INC/IL 9.0% 25,525,000 View
Feb 17, 2026 SCHEDULE 13G/A LAMPERT MARK N 9.0% 25,525,000 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Management, L.P. 9.9% 28,857,208 View
Feb 17, 2026 SCHEDULE 13G/A Peter Kolchinsky 9.9% 28,857,208 View
Feb 17, 2026 SCHEDULE 13G/A Rajeev Shah 9.9% 28,857,208 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Healthcare Fund, L.P. 9.9% 28,857,208 View
Feb 13, 2026 SCHEDULE 13G/A Maverick Capital, Ltd. 6.7% 18,970,913 View
Feb 13, 2026 SCHEDULE 13G/A Maverick Capital Management, LLC 6.7% 18,970,913 View
Feb 13, 2026 SCHEDULE 13G/A Lee S. Ainslie III 6.7% 18,970,913 View
Feb 12, 2026 SCHEDULE 13G/A Soleus Private Equity Fund III, L.P. 0.6% 1,680,160 View
Feb 12, 2026 SCHEDULE 13G/A Soleus Private Equity GP III, LLC 0.6% 1,680,160 View
Feb 12, 2026 SCHEDULE 13G/A Soleus PE GP III, LLC 0.6% 1,680,160 View
Feb 12, 2026 SCHEDULE 13G/A Soleus Capital Master Fund, L.P. 2.2% 6,028,567 View
Feb 12, 2026 SCHEDULE 13G/A Soleus Capital, LLC 2.2% 6,028,567 View
Feb 12, 2026 SCHEDULE 13G/A Soleus Capital Group, LLC 2.2% 6,028,567 View
Feb 12, 2026 SCHEDULE 13G/A Soleus Capital Management, L.P. 2.8% 7,708,727 View
Feb 12, 2026 SCHEDULE 13G/A Soleus GP, LLC 2.8% 7,708,727 View
Feb 12, 2026 SCHEDULE 13G/A Guy Levy 2.8% 7,708,727 View
Dec 29, 2025 SCHEDULE 13D/A — 7.3% — View
Nov 25, 2025 SCHEDULE 13G Perceptive Advisors LLC 7.9% 21,785,166 View
Nov 25, 2025 SCHEDULE 13G Joseph Edelman 7.9% 21,785,166 View
Nov 25, 2025 SCHEDULE 13G Perceptive Life Sciences Master Fund, Ltd. 7.9% 21,785,166 View
Nov 19, 2025 SCHEDULE 13D/A — 8.8% 21,687,906 View
Nov 14, 2025 SCHEDULE 13G/A Point72 Asset Management, L.P. 9.7% 20,372,479 View
Nov 14, 2025 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 9.7% 20,372,479 View
Nov 14, 2025 SCHEDULE 13G/A Steven A. Cohen 9.7% 20,372,479 View
Nov 14, 2025 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 12.1% 25,383,077 View
Nov 14, 2025 SCHEDULE 13G/A Janus Henderson Biotech Innovation Master Fund Ltd 10.3% 21,576,145 View
Nov 14, 2025 SCHEDULE 13G/A Deep Track Capital, LP 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 0.0% 0 View
Nov 14, 2025 SCHEDULE 13G/A David Kroin 0.0% 0 View
Nov 12, 2025 SCHEDULE 13D/A — 1.0% — View
Nov 07, 2025 SCHEDULE 13D/A — — — View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.